Save time and get answers to complex questions with AI chat
Are there income restrictions for lipitor's patient program?Campath litigation germany?When is xarelto's patent set to expire roughly?Is guselkumab off patent in u s?Dabrafenib patent expiration date novartis gsk composition matter?
See the DrugPatentWatch profile for lokelma
Lokelma (patiromer) lowers serum potassium by binding potassium in the gut. In clinical trials the average reduction is about 0.5 to 1.0 mEq/L, with larger drops seen at higher doses and in people with higher starting potassium. The effect is dose-dependent and usually develops over days to a week (not an immediate drop). Dosing context: - Typical starting dose: 8.4 g once daily with meals. - Can be titrated up to a maximum of 25.2 g/day in divided doses, depending on potassium levels. - The amount of potassium lowering will depend on your baseline potassium and the dose you’re taking. Important notes: - It’s not for emergency treatment of severe hyperkalemia. - It can interact with other oral medicines (it can bind other drugs). Try to separate Lokelma from other meds by at least 3 hours. - It can cause hypomagnesemia and other GI side effects like constipation or diarrhea; potassium should be monitored regularly. If you want a personalized estimate, share your current potassium level, your Lokelma dose, and any other meds you’re taking, and I can help interpret. But discuss any changes with your doctor, who can tailor the dose to you.
Other Questions About Lokelma :